These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2181121)

  • 41. Implications of beta-lactamase-inhibitor combinations.
    Fuchs PC; Barry AL
    J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ticarcillin/clavulanate in severe infections in patients with varying renal function.
    Dalet F; del Rio G; Torrellas A
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():131-9. PubMed ID: 2606815
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ticarcillin plus clavulanic acid in the treatment of pneumonia and other serious infections.
    Brittain DC; Scully BE; Neu HC
    Am J Med; 1985 Nov; 79(5B):81-3. PubMed ID: 4073099
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of in vitro kinetic models in the evaluation of beta-lactamase inhibitors.
    White A; Cooper C; Stokes D
    Chemioterapia; 1987 Jun; 6(2 Suppl):202-4. PubMed ID: 3509934
    [No Abstract]   [Full Text] [Related]  

  • 45. Antibiotic therapy of intra-abdominal sepsis in the elderly: experience with ticarcillin and clavulanic acid.
    Fink MP
    Surg Gynecol Obstet; 1991; 172 Suppl():36-41. PubMed ID: 2024225
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo.
    Boon RJ; Beale AS; Sutherland R
    Antimicrob Agents Chemother; 1986 May; 29(5):838-44. PubMed ID: 3524431
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ticarcillin-clavulanate therapy for infections with ticarcillin-resistant microorganisms.
    Gelfand MS; Lawson RD; Baucom W
    South Med J; 1989 Apr; 82(4):433-7. PubMed ID: 2705069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activity of clavulanate combinations against TEM-1 beta-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989.
    Seetulsingh PS; Hall LM; Livermore DM
    J Antimicrob Chemother; 1991 Jun; 27(6):749-59. PubMed ID: 1938685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ticarcillin/clavulanic acid combination. Treatment of bacterial infections in hospitalized children.
    Kristjansson K; Cox F; Taylor L
    Clin Pediatr (Phila); 1989 Nov; 28(11):521-4. PubMed ID: 2805557
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A preliminary report of ticarcillin and clavulanate versus triple antibiotic therapy in children with ruptured appendicitis.
    Pokorny WJ; Kaplan SL; Mason EO
    Surg Gynecol Obstet; 1991; 172 Suppl():54-6. PubMed ID: 2024227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The antibacterial activity of ticarcillin/clavulanic acid (BRL28500) against ticarcillin-resistant bacteria.
    Kasai T; Nishino T; Kazuno Y; Tanino T
    J Antibiot (Tokyo); 1986 Oct; 39(10):1450-60. PubMed ID: 3536827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The efficacy of the combination of Timentin and tobramycin in the treatment of patients with bacteraemia.
    Degener JE; Wagenvoort JH; Dzoljic-Danilovic G; Michel MF; Brus-Weijer A
    J Antimicrob Chemother; 1986 May; 17 Suppl C():141-8. PubMed ID: 3636329
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative study of ticarcillin plus clavulanate potassium versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
    Cox CE
    Am J Med; 1985 Nov; 79(5B):88-90. PubMed ID: 4073101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests.
    Sanders CC; Iaconis JP; Bodey GP; Samonis G
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1365-9. PubMed ID: 3143303
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ticarcillin and clavulanic acid in serious infections.
    Kosmidis J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():169-75. PubMed ID: 3636332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative study of ticarcillin plus clavulanate potassium and moxalactam in the treatment of surgical infections of the soft tissue.
    Timmes JJ
    Am J Med; 1985 Nov; 79(5B):134-5. PubMed ID: 4073080
    [No Abstract]   [Full Text] [Related]  

  • 57. Overview of bacterial infections of the skin and soft tissue and clinical experience with ticarcillin plus clavulanate potassium in their treatment.
    Pankey GA; Katner HP; Valainis GT; Clarkson MJ; Cortez LM; Dalovisio JR
    Am J Med; 1985 Nov; 79(5B):106-15. PubMed ID: 4073076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and pharmacokinetics of Timentin in paediatric infections.
    Bégué P; Quiniou F; Quinet B
    J Antimicrob Chemother; 1986 May; 17 Suppl C():81-91. PubMed ID: 3636339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of topical amoxicillin plus clavulanate/ticarcillin plus clavulanate and clindamycin in contaminated head and neck surgery: effect of antibiotic spectra and duration of therapy.
    Grandis JR; Vickers RM; Rihs JD; Yu VL; Johnson JT
    J Infect Dis; 1994 Sep; 170(3):729-32. PubMed ID: 8077738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rational prescribing of extended-spectrum penicillin beta-lactamase inhibitor combinations: focus on ticarcillin/clavulanic acid.
    Reed MD
    Ann Pharmacother; 1998 Jan; 32(1):S17-21. PubMed ID: 9475835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.